Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

With that as the backdrop, here's a closer look at three names that could be worth more than Berkshire Hathaway just five ...

The S&P 500 advanced 0.92% to 6,067.70, with technology shares seeing the biggest gains among sectors. The Technology Select ...

Stocks are pricey—but there are values to be had. Learn more about our panelists’ picks in this week’s Roundtable installment ...

President Trump’s chief cost-cutter cheered an effort to persuade federal workers to quit — in a fashion that closely ...

Health care, ride sharing, and the emerging world of YouTube entertainers are among industries leading investors have picked ...

Asit Sharma: Well, I am chilling with the fam, but in an alternate universe, Ricky, I'm showing up with a few beers and a pack of cards at your house to spend ... drug space after a monster 2022, 2023 ...

If Eli Lilly has its way, this may be the future ... in an interview with Business Insider. Like Ozempic, the new pill is designed to mimic the glucagon-like peptide 1 hormone that our bodies ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...

We recently compiled a list of the 7 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at where Eli ...